Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-24 @ 4:01 PM
NCT ID:
NCT06390566
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of autosomal recessive LGMD2A (two pathogenic mutations in the calpain 3 gene)
* Ability to participate in the tests and examinations planned by the study (manual muscle tests, motor scales)
* Informed and having signed a consent form
* Affiliate to a social security scheme in France (beneficiary or entitled person).
Exclusion Criteria:
* Patient with another disease likely to significantly interfere with the interpretation of the natural history of LGMD2A
* Participant in a clinical trial with an investigational product within 3 months preceding inclusion
* Patient unable or unwilling to comply with protocol requirements
* Patient under guardianship, curatorship or legal protection
* Pregnant or breastfeeding woman
* Patient deprived of liberty
* Adult patient unable to express consent
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06390566
Study Brief:
Protocol Section:
NCT06390566